Non-HLA-type endothelial cell reactive alloantibodies in pre-transplant sera of kidney recipients trigger apoptosis

American Journal of Transplantation

Volumn 3, Issue 2, 2003, Pages 167-177

  Le Bas Bernardet, Stéphanie ^a   Hourmant, Maryvonne ^a   Coupel, Stéphanie ^a   Bignon, Jean Denis ^b   Soulillou, Jean Paul ^a   Charreau, Béatrice ^a  

^a HÔTEL DIEU   (France)

^b ETABLISSEMENT FRANÇAIS DU SANG   (France)

Author keywords

Alloantibodies; Apoptosis; Endothelial cells; HLA; Kidney; Transplantation

Indexed keywords

ALLOANTIBODY; DNA FRAGMENT; GAMMA INTERFERON; HLA ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ACUTE GRAFT REJECTION; ALLOIMMUNITY; ANTIGEN BINDING; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; APOPTOSIS; ARTICLE; B LYMPHOCYTE; BLOOD GROUP ABO SYSTEM; CELL VIABILITY; CONTROLLED STUDY; ENDOTHELIUM CELL; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GRAFT SURVIVAL; HLA TYPING; HUMAN; HUMAN CELL; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; VASCULAR ENDOTHELIUM;

ANTIBODY SPECIFICITY; ANTIGENS, SURFACE; APOPTOSIS; AUTOANTIBODIES; ENDOTHELIUM, VASCULAR; FEMALE; FLOW CYTOMETRY; HLA ANTIGENS; HUMANS; IMMUNIZATION, PASSIVE; INTERFERON TYPE II; ISOANTIBODIES; KIDNEY TRANSPLANTATION; MALE; REFERENCE VALUES; RETROSPECTIVE STUDIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037296105     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-6143.2003.00021.x     Document Type: Article

References (38)

1. Pober J, Orosz CG, Rose ML, Savage CO. Can graft endothelial cells initiate a host anti-graft immune response? Transplantation 1996; 61: 343-349.
2. Sumitran-Holgerson S. HLA-specific alloantibodies and renal graft outcome. Nephrol Dial Transplant 2001; 16: 897-904.
3. McKenna RM, Takemoto SK, Terasaki PI. Anti HLA antibodies after solid organ transplantation. Transplantation 2000; 69: 319-326.
4. Libby P, Pober JS. Chronic rejection. Immunity 2001; 14: 387-397.
5. Del Papa N, Guidali L, Sironi M et al. Anti-endothelial cell IgG antibodies from patients with Wegener's granulomatosis bind to human endothelial cells in vitro and induce adhesion molecule expression and cytokine secretion. Arthritis Rheum 1996; 39: 758-766.
6. Heurkens AH, Daha MR, Breedveld FC. Anti-endothelial cell antibodies in patients with rheumatoid vasculitis. Arthritis Rheum 1989; 32: 1191-1192.
7. Lunardi C, Bason C, Navone R et al. Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells. Nat Med 2000; 6: 1183-1186.
8. Carvalho D, Savage CO, Black CM, Pearson JD. IgG antiendothelial cell autoantibodies from scleroderma patients induce leukocyte adhesion to human vascular endothelial cells in vitro. Induction of adhesion molecule expression and involvement of endothelium-derived cytokines. J Clin Invest 1996; 97: 111-119.
9. Bordron A, Dueymes M, Levy Y et al. The binding of some human antiendothelial cell antibodies induces endothelial cell apoptosis. J Clin Invest 1998; 101: 2029-2035.
10. Cerilli J, Brasile L, Galouzis T, Lempert N, Clarke J. The vascular endothelial cell antigen system. Transplantation 1985; 39: 286-289.
11. Paul LC, Baldwin WM, 3rd, van Es LA. Vascular endothelial alloantigens in renal transplantation. Transplantation 1985; 40: 117-123.
12. Dunn MJ, Crisp SJ, Rose ML, Taylor PM, Yacoub MH. Antiendothelial antibodies and coronary artery disease after cardiac transplantation. Lancet 1992; 339: 1566-1570.
13. Ferry BL, Welsh KI, Dunn MJ et al. Anti-cell surface endothelial antibodies in sera from cardiac and kidney transplant recipients: association with chronic rejection. Transpl Immunol 1997; 5: 17-24.
14. Faulk WP, Rose M, Meroni PL et al. Antibodies to endothelial cells identify myocardial damage and predict development of coronary artery disease in patients with transplanted hearts. Hum Immunol 1999; 60: 826-832.
15. Toyoda M, Galfayan K, Galera OA, Petrosian A, Czer LS, Jordan SC. Cytomegalovirus infection induces anti-endothelial cell antibodies in cardiac and renal allograft recipients. Transpl Immunol 1997; 5: 104-111.
16. Youinou P, Meroni PL, Khamashta MA, Shoenfeld Y. A need for standardization of the anti-endothelial-cell antibody test. Immunol Today 1995; 16: 363-364.
17. Le Bas-Bernardet S, Hourmant M, Valentin N et al. Identification of the antibodies involved in B cell crossmatch positivity in renal transplantation. Transplantation 2002; in press.
18. Charreau B, Coupel S, Goret F, Pourcel C, Soulillou JP. Association of glucocorticoids and cyclosporin A or rapamycin prevents E-selectin and IL-8 expression during LPS- and TNFalpha-mediated endothelial cell activation. Transplantation 2000; 69: 945-953.
19. Charreau B, Coupel S, Boulday G, Soulillou JP. Cyclosporine inhibits class II major histocompatibility antigen presentation by xenogeneic endothelial cells to human T lymphocytes by altering expression of the class II transcriptional activator gene. Transplantation 2000; 70: 354-361.
20. Lapierre LA, Fiers W, Pober JS. Three distinct classes of regulatory cytokines control endothelial cell MHC antigen expression. Interactions with immune gamma interferon differentiate the effects of tumor necrosis factor and lymphotoxin from those of leukocyte alpha and fibroblast beta interferons. J Exp Med 1988; 167: 794-804.
21. Markus BH, Colson YL, Fung JJ, Zeevi A, Duquesnoy RJ. HLA antigen expression on cultured human arterial endothelial cells. Tissue Antigens 1988; 32: 241-253.
22. Pober JS, Cotran RS. The role of endothelial cells in inflammation. Transplantation 1990; 50: 537-544.
23. Kekomaki S, Kyllonen L, Salmela K, Koskimies S, Kekomaki R. Platelet-specific alloantigens in cadaveric renal transplantation. A prospective study. Effect of HPA-5b mismatch in acute vascular rejection of renal allografts. Tissue Antigens 2001; 57: 154-157.
24. Bach FH, Hancock WW, Ferran C. Protective genes expressed in endothelial cells: a regulatory response to injury. Immunol Today 1997; 18: 483-486.
25. Boulday G, Coupel S, Coulon F, Soulillou JP, Charreau B. Antigraft antibody-mediated expression of metalloproteinases on endothelia cells. Differential expression of TIMP-1 and ADAM-10 depends on antibody specificity and isotype. Circ Res 2001; 88: 430-437.
26. Sandrin MS, Vaughan HA, Dabkowski PL, McKenzie IF. Anti-pig IgM antibodies in human serum react predominantly with Galα1-3Gal epitopes. Proc Natl Acad Sci USA 1993; 90: 11391-11395.
27. Parker W, Lundberg-Swanson K, Holzknecht ZE et al. Isohemagglutinins and xenoreactive antibodies: members of a distinct family of natural antibodies. Hum Immunol 1996; 45: 94-104.
28. Shaw PX, Horkko S, Chang MK et al. Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J Clin Invest 2000; 105: 1731-40.
29. Ehrenstein MR, O'Keefe TL, Davies SL, Neuberger MS. Targeted gene disruption reveals a role for natural secretory IgM in the maturation of the primary immune response. Proc Natl Acad Sci USA 1998; 95: 10089-10093.
30. Hancock WW, Buelow R, Sayegh MH, Turka LA. Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes. Nat Med 1998; 4: 1392-1396.
31. Lagaaij EL, Cramer-Knijnenburg GF, van Kemenade FJ, van Es LA, Bruijn JA, van Krieken JH. Endothelial cell chimerism after renal transplantation and vascular rejection. Lancet 2001; 357: 33-37.
32. Hillebrands JL, Klatter FA, van den Hurk BM, Popa ER, Nieuwenhuis P, Rozing J. Origin of neointimal endothelium and alpha-actin-positive smooth muscle cells in transplant arteriosclerosis. J Clin Invest 2001; 107: 1411-1422.
33. Xu B, Sakkas LI, Slachta CA et al. Apoptosis in chronic rejection of human cardiac allografts. Transplantation 2001; 71: 1137-1146.
34. Lederer SR, Kluth-Pepper B, Schneeberger H, Albert E, Land W, Feucht HE. Impact of humoral alloreactivity early after transplantation on the long-term survival of renal allografts. Kidney Int 2001; 59: 334-341.
35. Bian H, Harris PE, Mulder A, Reed EF. Anti-HLA antibody ligation to HLA class I molecules expressed by endothelial cells stimulates tyrosine phosphorylation, inositol phosphate generation, and proliferation. Hum Immunol 1997; 53: 90-97.
36. Smith JD, Lawson C, Yacoub MH, Rose ML. Activation of NF-kappa B in human endothelial cells induced by monoclonal and allospecific HLA antibodies. Int Immunol 2000; 12: 563-571.
37. Salama A, Delikouras A, Pusey C et al. Transplant accommodation in highly sensitized patients: a potential role for Bcl-XL and alloantibody. Am J Transplant 2001; 1: 260-269.
38. Bian H, Reed EF. Alloantibody-mediated class I signal transduction in endothelial cells and smooth muscle cells: enhancement by IFN-gamma and TNF-alpha. J Immunol 1999; 163: 1010-1018.